Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer

The Uromigos - A podcast by The Uromigos

Podcast artwork

Petros Grivas describes the results of this phase 2 trial.

Visit the podcast's native language site